Startups + VC
Neuronoff raises $4.5 million to bring needle-based chronic pain treatment to market
Cleveland-based Neuronoff raised $4.5M to bring its Injectrode—an injectable, minimally invasive chronic pain treatment—to market by 2026, offering a drug-free, surgery-free alternative to traditional neuromodulation therapies.